Competitors ahead of us have failed with the TSS and that's what...

  1. 914 Posts.
    lightbulb Created with Sketch. 579
    Competitors ahead of us have failed with the TSS and that's what the FDA hold in the highest regard.

    Safety profile paramount in this patient population. You can see why Hashan thinks in the long run, SNT-5505 could potentially be part of the standard of care in the early patient population = big $$$
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
5.7¢
Change
-0.001(1.72%)
Mkt cap ! $92.62M
Open High Low Value Volume
5.8¢ 5.9¢ 5.6¢ $174.0K 3.073M

Buyers (Bids)

No. Vol. Price($)
4 83031 5.5¢
 

Sellers (Offers)

Price($) Vol. No.
5.7¢ 483082 1
View Market Depth
Last trade - 16.10pm 18/06/2025 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.